GREGORY LEVINE — Lobbyist Profile | Poliscope

GREGORY LEVINE

Reported covered position: N/A

Filings

Clients

Firms

Years active

2005–2007

Associated filing income

$940,000

How to read the money

Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.

Clients represented

Client	Filings	Years
GENENTECH INC	3	2005–2006
PFIZER, INC.	3	2006–2007
BIOTECHNOLOGY INDUSTRY ORGANIZATION	2	2006

Lobbying firms

Firm	Filings	Years
ARNOLD & PORTER KAYE SCHOLER LLP	8	2005–2007

Bills explicitly cited in this lobbyist’s assigned issues (1)

No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.

S. 3678

Pandemic and All-Hazards Preparedness Act

Client: BIOTECHNOLOGY INDUSTRY ORGANIZATION · Firm: ARNOLD & PORTER KAYE SCHOLER LLP

Open original LDA filing ↗

Cited source text

H.R. 5533: Biodefense Pandemic Vaccine & Drug Development Act of 2006 S. 3678: Pandemic & All-Hazards Preparedness Act

Original LDA source filings (8)

Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.

PFIZER INC via ARNOLD & PORTER KAYE SCHOLER LLP

2007 · mid_year · MM

Firm income: $60,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

MED

Medical/Disease Research/Clinical Labs

Issues related to biodefense legislation. Issues related to drug safety legislation. Issues related to drug user fee legislation. Issues related to healthcare legislation.

Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

GENENTECH INC via ARNOLD & PORTER KAYE SCHOLER LLP

2006 · year_end · YY

Firm income: $320,000

Source: Senate LDA